Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants
Sponsor: UCB Biopharma SRL
Summary
The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants
Official title: A Phase 1, Randomized, Placebo-Controlled Single Ascending Dose Participant- and Investigator-Blind Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-12-08
Completion Date
2026-12-13
Last Updated
2025-12-23
Healthy Volunteers
Yes
Conditions
Interventions
UCB5285
Participants will receive UCB5285 as prespecified in each cohort.
Placebo
Participants will receive matching placebo as prespecified in each cohort.
Locations (1)
Up0161 1001
Harrow, United Kingdom